[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aclarion Inc WT (ACONW)

Aclarion Inc WT (ACONW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment

“Matching the right procedure to the right patient is what moves the field forward” Lanman Spinal Neurosurgery is a leading spine-focused private practice recognized for its expertise in complex...

ACONW : 0.0334 (+0.30%)
ACON : 3.18 (+0.79%)
Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.

BROOMFIELD, Colo., May 06, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. , (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging...

ACONW : 0.0334 (+0.30%)
ACON : 3.18 (+0.79%)
Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine

BROOMFIELD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc.,  (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),  a commercial-stage healthcare technology company that is leveraging...

ACONW : 0.0334 (+0.30%)
ACON : 3.18 (+0.79%)
Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Triple-digit annual growth signals accelerating Nociscan adoption and integration into clinical workflows Advancing reimbursement and clinical milestones, with CLARITY trial interim readout anticipated...

ACONW : 0.0334 (+0.30%)
ACON : 3.18 (+0.79%)
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Commercial leader with proven track record of driving growth, surgeon adoption, and market expansion with innovative spine and surgical technologies Expansion of commercial team reflects increasing...

ACONW : 0.0334 (+0.30%)
ACON : 3.18 (+0.79%)
Aclarion Announces $2.5 Million Stock Repurchase Plan

BROOMFIELD, Colo., April 22, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc .,  (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),  a commercial-stage healthcare technology company leveraging biomarkers...

ACONW : 0.0334 (+0.30%)
ACON : 3.18 (+0.79%)
Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

Patent covers use of AI in workflows of future products to accelerate company’s ability to scale and enhance already strong gross margins Expands intellectual property portfolio to 64 issued and...

ACONW : 0.0334 (+0.30%)
ACON : 3.18 (+0.79%)
Aclarion Receives Pinnacle Award for AI Innovation

Recognition Follows 2025 HLTH Digital Health Award for Nociscan Award Winning AI Targets a Large and Costly Chronic Low Back Pain Market BROOMFIELD, Colo., April 14, 2026 (GLOBE NEWSWIRE) --...

ACONW : 0.0334 (+0.30%)
ACON : 3.18 (+0.79%)
Aclarion Announces Agreement with Weill Cornell Medicine

BROOMFIELD, Colo., April 08, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc.,  (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),  a commercial-stage healthcare technology company that is leveraging...

ACONW : 0.0334 (+0.30%)
ACON : 3.18 (+0.79%)
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

Video featuring Mr. John Sutcliffe, Lead Clinician at The London Spine Clinic, highlights real-world physician experience with Nociscan in clinical practice Nearly 100 Nociscans performed at The London...

ACONW : 0.0334 (+0.30%)
ACON : 3.18 (+0.79%)

Barchart Exclusives

JPMorgan vs. Bank of America: How the 2 Dividend-Paying Bank Stocks Stack Up in 2026
JPMorgan dominates on scale and profits, while Bank of America wins on value and yield. Here's which big bank stock deserves your money in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.